gms | German Medical Science

69. Jahrestagung der Deutschen Gesellschaft für Neurochirurgie (DGNC)
Joint Meeting mit der Mexikanischen und Kolumbianischen Gesellschaft für Neurochirurgie

Deutsche Gesellschaft für Neurochirurgie (DGNC) e. V.

03.06. - 06.06.2018, Münster

Value of intraoperative MRI for resection control in microscopic transsphenoidal pituitary surgeryery

Meeting Abstract

  • Andreas W. Unterberg - Universitätsklinikum Heidelberg, Neurochirurgische Klinik, Heidelberg, Deutschland
  • Beynon Christopher - Universitätsklinikum Heidelberg, Neurochirurgische Klinik, Heidelberg, Deutschland
  • Karsten Geletneky - Universitätsklinikum Heidelberg, Neurochirurgische Klinik, Heidelberg, Deutschland
  • Stefan Hähnel - Universitätsklinikum Heidelberg, Neuroradiologie, Heidelberg, Deutschland
  • Martin Bendszus - Universitätsklinikum Heidelberg, Neuroradiologie, Heidelberg, Deutschland
  • Moritz Scherer - Universitätsklinikum Heidelberg, Neurochirurgische Klinik, Heidelberg, Deutschland

Deutsche Gesellschaft für Neurochirurgie. 69. Jahrestagung der Deutschen Gesellschaft für Neurochirurgie (DGNC), Joint Meeting mit der Mexikanischen und Kolumbianischen Gesellschaft für Neurochirurgie. Münster, 03.-06.06.2018. Düsseldorf: German Medical Science GMS Publishing House; 2018. DocV162

doi: 10.3205/18dgnc165, urn:nbn:de:0183-18dgnc1652

Veröffentlicht: 18. Juni 2018

© 2018 Unterberg et al.
Dieser Artikel ist ein Open-Access-Artikel und steht unter den Lizenzbedingungen der Creative Commons Attribution 4.0 License (Namensnennung). Lizenz-Angaben siehe http://creativecommons.org/licenses/by/4.0/.


Gliederung

Text

Objective: Recent series analysing the utility of intraoperative MRI (iMRI) in transsphenoidal pituitary surgery suggest that the rate of complete resections can be significantly increased while the rate of pituitary insufficiency remains unaffected. Since iMRI is time-consuming and costly however, it would be desirable to better identify and characterize patients in whom iMRI would result in additional resections.

Methods: From 01/2010 to 10/2017, a total of 438 consecutive patients were prospectively assessed in a registry. The series comprises all Knosp grades (0-4), micro-(17.3%) and macroadenomas (82.7%), hormone-active (38.8%) and inactive tumors (61.2%), primary surgeries (n=396, 90.5%) and secondary interventions for recurrencies (n=42, 9.5%). Intraoperatively, a 1.5Tesla scanner was used. Intraoperative scans were conjointly evaluated by neuroradiologists and neurosurgeons. Univariate regression was calculated to identify variables of additional adenoma resection after iMRI.

Results: The iMRI suspected tumor remnants of 174/438 cases (39.7%). Transsphenoidal re-inspection resulted in an additional curettage of adenomas in only 73 cases, however (16.7%). In 61 patients (13.9%), no remnants could be identified. In 40 patients (9.1%), tumour remnants could not be reached due to their para- or suprasellar location. E.g. adenoma satellites already recognized preoperatively, could often not be resected transsphenoidally (18 pts., 4.0%). In univariate regression, adenoma size, parasellar location and recurrent surgery increased the likelihood for an additional adenoma resection after iMRI. Further analysis revealed that an increasing surgical experience is associated with better prediction of tumour remnants, indicating that iMRI is especially valuable in training.

Conclusion: In the majority of cases in this series, pituitary adenomas were completely removed transsphenoidally without the adjunct of iMRI. Thus, iMRI for resection control in microsurgical transsphenoidal pituitary surgery offers limited benefits. Particularly in recurrent surgeries and in large adenomas with para- and suprasellar extension, however, iMRI is a valuable tool to increase the rate of complete adenoma removal. Stratification of cases according to these preconditions can assist to efficiently use iMRI in pituitary surgery.